{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:58:54Z","timestamp":1788044334112,"version":"build-2784847793"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.det.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T18:03:49Z","timestamp":1566842629000},"page":"455-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cutaneous T Cell Lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Erik","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Weed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Lo Sicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Ann","family":"Latkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2019.05.007_bib1","author":"National Comprehensive Cancer Network"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib2","first-page":"717","article-title":"Denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"2","author":"Kaminetzky","year":"2008","journal-title":"Biologics"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2040620716636541","article-title":"Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential","volume":"7","author":"Duvic","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.det.2019.05.007_bib4","series-title":"Dermatology","author":"Bolognia","year":"2018"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03705.x","article-title":"Cutaneous T cell lymphoma","volume":"941","author":"Edelson","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.det.2019.05.007_bib6","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8829.1","article-title":"An overview of cutaneous T cell lymphomas","volume":"5","author":"Bagherani","year":"2016","journal-title":"F1000Res"},{"issue":"10","key":"10.1016\/j.det.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"EORTC classification for primary cutaneous lymphomas. A proposal from the Cutaneous Lymphoma Study Group\u00a0of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.det.2019.05.007_bib8","first-page":"1","article-title":"Current and emerging therapeutics for cutaneous T-cell lymphoma: histone deacetylase inhibitors","volume":"2012","author":"Rodd","year":"2012","journal-title":"Lymphoma"},{"issue":"7","key":"10.1016\/j.det.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.hoc.2008.07.014","article-title":"Cutaneous T-cell lymphoma","volume":"22","author":"Lansigan","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000438669","article-title":"Human endogenous retrovirus expression in primary cutaneous T-cell lymphomas","volume":"232","author":"Fava","year":"2016","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.det.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"e970025","DOI":"10.4161\/21624011.2014.970025","article-title":"Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma","volume":"3","author":"Litvinov","year":"2014","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.det.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin \u03b1 and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget"},{"issue":"31","key":"10.1016\/j.det.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"31868","DOI":"10.18632\/oncotarget.5573","article-title":"EPHA4 is overexpressed but not functionally active\u00a0in S\u00e9zary syndrome","volume":"6","author":"Hameetman","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.det.2019.05.007_bib17","article-title":"Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma","author":"Dulmage","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.det.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/DAD.0b013e318276cc68","article-title":"Expression of PTEN in mycosis fungoides and correlation with loss of heterozygosity","volume":"35","author":"Katona","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.det.2019.05.007_bib19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/PAS.0b013e3180408d76","article-title":"Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression","volume":"31","author":"Katona","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.det.2019.05.007_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/bjd.12578","article-title":"Lessons learned from gene expression profiling of cutaneous T-cell lymphoma","volume":"169","author":"Dulmage","year":"2013","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib23","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/1078-0432.CCR-14-3322","article-title":"The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL)","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.det.2019.05.007_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and MF arise from distinct T cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.det.2019.05.007_bib25","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma","volume":"6","author":"Sibbesen","year":"2015","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.det.2019.05.007_bib26","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/1078-0432.CCR-15-1784","article-title":"STAT3\/5 dependent IL-9 overexpression contributes to neoplastic cell survival in mycosis fungoides","volume":"22","author":"Vieyra-Garcia","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib27","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.18632\/oncotarget.6916","article-title":"Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma","volume":"7","author":"Ikeda","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5114\/pdia.2015.48034","article-title":"Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides","volume":"32","author":"Maj","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000440856","article-title":"Koebner phenomenon and mycosis fungoides","volume":"7","author":"Lebas","year":"2015","journal-title":"Case Rep Dermatol"},{"issue":"10","key":"10.1016\/j.det.2019.05.007_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcus aureus enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","volume":"127","author":"Willerslev-Olsen","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.det.2019.05.007_bib31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2340\/00015555-2337","article-title":"Mycosis fungoides: a retrospective study of 44 Swedish cases","volume":"96","author":"Eklund","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0019-5154.156423","article-title":"Evaluation of the association between Epstein-Barr virus and mycosis fungoides","volume":"60","author":"Nahidi","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"5100","key":"10.1016\/j.det.2019.05.007_bib33","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1126\/science.8451645","article-title":"HTLV-1 provirus and mycosis fungoides","volume":"259","author":"Whittaker","year":"1993","journal-title":"Science"},{"issue":"308","key":"10.1016\/j.det.2019.05.007_bib34","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib35","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1188\/15.CJON.E131-E139","article-title":"Optimizing care and compliance for the treatment of mycosis fungoides cutaneous T-cell lymphoma with mechlorethamine gel","volume":"19","author":"Benjamin Chase","year":"2015","journal-title":"Clin J Oncol Nurs"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/00000478-199512000-00009","article-title":"Reassessment of histologic parameters in the diagnosis of mycosis fungoides","volume":"19","author":"Smoller","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.det.2019.05.007_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0733-8635(18)30181-5","article-title":"Controversies and discussion on early diagnosis of cutaneous T-cell lymphoma: phenotyping","volume":"12","author":"Ralfkiaer","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2019.05.007_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1523-1747.ep12371791","article-title":"CD7-negative helper T cells accumulate in inflammatory skin lesions","volume":"102","author":"Moll","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib40","series-title":"Dermatopathology","article-title":"Chapter 24. Cutaneous T-cell lymphoma, NK-cell lymphoma, and myeloid leukemia","author":"DiCaudo","year":"2018"},{"key":"10.1016\/j.det.2019.05.007_bib41","series-title":"NCCN clinical practice guidelines in oncology: non-Hodgkin\u2019s lymphomas","author":"National Comprehensive Care Network","year":"2015"},{"issue":"7","key":"10.1016\/j.det.2019.05.007_bib42","doi-asserted-by":"crossref","first-page":"A438","DOI":"10.1016\/j.jval.2015.09.1065","article-title":"Systematic review of burden of cutaneous T-cell lymphoma","volume":"18","author":"Aggarwal","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.det.2019.05.007_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1747.2000.00040.x","article-title":"Detection of expanded T-cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T-cell receptor-gamma polymerase chain reaction assays","volume":"115","author":"Lukowski","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-0142(19920201)69:3<717::AID-CNCR2820690319>3.0.CO;2-I","article-title":"Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients","volume":"69","author":"Rijlaarsdam","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0972-3919.158527","article-title":"The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides","volume":"30","author":"Alanteri","year":"2015","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.det.2019.05.007_bib46","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2008.04.018","article-title":"Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease","volume":"59","author":"Lee","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib49","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archdermatol.2008.46","article-title":"Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC)","volume":"144","author":"Kempf","year":"2008","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00128071-200708010-00008","article-title":"Topical nitrogen mustard for the treatment of granulomatous slack skin","volume":"8","author":"Hultgren","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000069967","article-title":"Granulomatous slack skin: treatment with extensive surgery and review of the literature","volume":"206","author":"Clarijs","year":"2003","journal-title":"Dermatology"},{"issue":"15","key":"10.1016\/j.det.2019.05.007_bib52","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib53","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.05.007_bib54","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib56","series-title":"Human lymphoma: clinical implications of the REAL classification","first-page":"197","article-title":"Subcutaneous panniculitis-like T cell lymphoma","author":"Jaffe","year":"1999"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"\u00c7etin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.det.2019.05.007_bib59","first-page":"1941","article-title":"Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas","volume":"150","author":"Bakels","year":"1997","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.det.2019.05.007_bib60","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6602502","article-title":"Nasal-type NK\/T cell lymphoma: clinical features and treatment outcome","volume":"92","author":"Lee","year":"2005","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.05.007_bib62","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11899-007-0033-z","article-title":"Management of advanced-stage peripheral T-cell lymphomas","volume":"2","author":"Kimby","year":"2007","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.det.2019.05.007_bib64","series-title":"Rare malignant skin tumors","first-page":"295","article-title":"Primary cutaneous \u03b3\/\u03b4 T-cell lymphoma","author":"Kempf","year":"2015"},{"issue":"8","key":"10.1016\/j.det.2019.05.007_bib65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2230.2010.03849.x","article-title":"Primary cutaneous peripheral T-cell lymphoma, unspecified with\u00a0an indolent clinical course: a distinct peripheral T-cell lymphoma?","volume":"35","author":"Ryan","year":"2010","journal-title":"Clin Exp Dermatol Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib67","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A\u00a0randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"32","key":"10.1016\/j.det.2019.05.007_bib68","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.det.2019.05.007_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/pdia.2014.40941","article-title":"Follow-up of patients with mycosis fungoides after interferon \u03b12b treatment failure","volume":"32","author":"Chmielowska","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.det.2019.05.007_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00373429","article-title":"The effect of glycerol and humidity on desmosome degradation in stratum corneum","volume":"287","author":"Rawlings","year":"1995","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.det.2015.05.004","article-title":"Skin-directed therapies in cutaneous T-cell lymphoma","volume":"33","author":"Nguyen","year":"2015","journal-title":"Dermatol Clin"},{"issue":"11","key":"10.1016\/j.det.2019.05.007_bib72","first-page":"20","article-title":"Topical corticosteroid application and the structural and functional integrity of the epidermal barrier","volume":"6","author":"Del Rosso","year":"2013","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000236781","article-title":"Glucocorticoid-induced apoptosis of lymphoid cells","volume":"105","author":"Schwartzman","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1396-0296.2003.01639.x","article-title":"Treatment of patch-stage mycosis fungoides with topical corticosteroids","volume":"16","author":"Zackheim","year":"2003","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2019.05.007_bib75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.det.2015.05.007","article-title":"The role of systemic retinoids in the treatment of cutaneous T-cell lymphoma","volume":"33","author":"Huen","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2019.05.007_bib76","doi-asserted-by":"crossref","first-page":"254560","DOI":"10.1155\/2015\/254560","article-title":"Identification of Bexarotene as a PPAR Antagonist with HDX","volume":"2015","author":"Marciano","year":"2015","journal-title":"PPAR Res"},{"key":"10.1016\/j.det.2019.05.007_bib77","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3816\/CLM.2000.s.008","article-title":"Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL)","volume":"1","author":"Burg","year":"2000","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.det.2019.05.007_bib78","first-page":"1129","article-title":"Synthetic retinoids in dermatology","volume":"132","author":"Heller","year":"1985","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.det.2019.05.007_bib79","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jnci\/84.4.241","article-title":"13-cis-retinoic acid plus interferon-2a: highly active systemic therapy for squamous cell carcinoma of the cervix","volume":"84","author":"Lippman","year":"1992","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib80","first-page":"117","article-title":"Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma","volume":"146","author":"Suarez","year":"2016","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.det.2019.05.007_bib81","doi-asserted-by":"crossref","first-page":"e0146115","DOI":"10.1371\/journal.pone.0146115","article-title":"The therapeutic potential of AN-7, a novel histone deacetylase inhibitor, for treatment of mycosis fungoides\/S\u00e9zary syndrome alone or with doxorubicin","volume":"11","author":"Moyal","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.det.2019.05.007_bib82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mjd.2002.120911","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides","volume":"47","author":"Gathers","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","article-title":"Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy","volume":"141","author":"Querfield","year":"2005","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.det.2019.05.007_bib84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1468-3083.2006.01635.x","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes","volume":"20","author":"G\u00f6kdemir","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2019.05.007_bib85","first-page":"429068","article-title":"Primary cutaneous peripheral T-cell lymphoma not otherwise specified: a rapidly progressive variant of cutaneous T-cell lymphoma","volume":"2015","author":"Aderhold","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.det.2019.05.007_bib86","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"issue":"25","key":"10.1016\/j.det.2019.05.007_bib87","first-page":"2765","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma (vol 126, pg 1452, 2015)","volume":"126","author":"Rook","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.det.2019.05.007_bib88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.critrevonc.2015.12.018","article-title":"Panoptic clinical review of the current and future treatment of relapsed\/refractory T-cell lymphomas: cutaneous T-cell lymphomas","volume":"99","author":"Zinzani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.prro.2015.10.021","article-title":"Adaptation of the Stanford technique for treatment of bulky cutaneous T-cell lymphoma of the head","volume":"6","author":"Ahmed","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib90","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/php.12521","article-title":"Epigenetically Enhanced Photodynamic Therapy (ePDT) is superior to conventional photodynamic therapy for inducing apoptosis in cutaneous T-cell lymphoma","volume":"91","author":"Salva","year":"2015","journal-title":"Photochem Photobiol"},{"issue":"6","key":"10.1016\/j.det.2019.05.007_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bmt.1704641","article-title":"Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation","volume":"34","author":"Herbert","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"32","key":"10.1016\/j.det.2019.05.007_bib92","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.det.2019.05.007_bib93","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/bjd.12690","article-title":"Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas","volume":"170","author":"de Masson","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2019.05.007_bib94","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"13","key":"10.1016\/j.det.2019.05.007_bib95","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A\u00a0cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.det.2019.05.007_bib96","article-title":"Unusual involvement in mycosis fungoides: duodenal papilla","volume":"10","author":"Gomez Venegas","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"issue":"9","key":"10.1016\/j.det.2019.05.007_bib97","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/jid.2015.221","article-title":"PLCG1 gene mutations in cutaneous T-cell lymphomas revisited","volume":"135","author":"Tensen","year":"2015","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351930049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351930049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:44:28Z","timestamp":1760006668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351930049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S073386351930049X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2019.05.007","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous T Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}